483 Changzhou Ruiming Pharmaceuticals Jul 2015

483 Changzhou Ruiming Pharmaceuticals Jul 2015

Cheryl Clausen FDA, Angela Glenn FDA$119.00 - Available Now

FDA investigators audited the Changzhou Ruiming Pharmaceuticals - Changzhou, China facility and issued inspectional observations (via FDA 483) on 17 Jul 2015.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Jul 2015
  • Location: Changzhou, China
  • FEI: 3007086821
Add To Cart